Definium Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| May 2019 | — | $0 | — |
| Dec 2019 | — | $4.8M | — |
| Dec 2020 | — | $75.9M | $80.1M |
| Mar 2021 | — | $180.6M | — |
| Jun 2021 | — | $171.6M | — |
| Sep 2021 | — | $164.3M | — |
| Dec 2021 | — | $151.7M | $133.5M |
| Mar 2022 | — | $136.8M | $120.5M |
| Jun 2022 | — | $124.5M | $105.7M |
| Sep 2022 | — | $153.6M | $154.5M |
| Dec 2022 | — | $150.9M | $142.1M |
| Mar 2023 | — | $130.3M | $129.4M |
| Jun 2023 | — | $106.0M | $116.9M |
| Sep 2023 | $14.1M | $96.0M | $117.7M |
| Dec 2023 | $14.1M | $78.1M | $99.7M |
| Mar 2024 | $14.2M | $196.1M | $252.3M |
| Jun 2024 | $24.3M | $202.0M | $243.1M |
| Sep 2024 | $24.3M | $262.2M | $295.3M |
| Dec 2024 | $21.9M | $241.4M | $273.7M |
| Mar 2025 | $22.0M | $222.8M | $82.9M |
| Jun 2025 | $41.2M | $185.4M | $33.4M |
| Sep 2025 | $40.4M | $130.6M | $20.0M |
| Dec 2025 | $40.6M | $332.3M | $257.8M |
| Mar 2026 | $40.8M | $278.8M | $262.5M |
| Jun 2026 | $36.5M | $918.7M | $655.3M |